Interacting Drugs |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Tocilizumab |
Security Level |
 |
Mechanism |
Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates. |
Management |
Monitor therapy |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Tocilizumab
Post Review about Bacitracin, neomycin, polymyxin B, and hydrocortisone vs Tocilizumab Click here to cancel reply.
Other Interactions of Bacitracin, neomycin, polymyxin B, and hydrocortisone
Other Interactions of Tocilizumab
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.